Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Y. Graham

Showing results (91-100 of 373) with videos related to

Pageof 38
Sort By:
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 16, 2011
Paxillin is a novel cellular target for converging Helicobacter pylori-induced cellular signalingFazal H Tabassam, David Y Graham, Yoshio Yamaoka
Helicobacter|December 6, 2007
Contemplating the future without Helicobacter pylori and the dire consequences hypothesisDavid Y Graham, Yoshio Yamaoka, Hoda M Malaty
Clinical Medicine Insights. Case Reports|July 26, 2013
Toothpick perforation of the intestines presenting as recurrent abdominal pain: possible roles of abdominal ultrasound and MRIRobert J Sealock, Saman Sabounchi, David Y Graham
Nature Reviews. Gastroenterology & Hepatology|February 5, 2011
Optimal therapy for Helicobacter pylori infectionsEmiko Rimbara, Lori A Fischbach, David Y Graham
Cellular Microbiology|December 11, 2007
OipA plays a role in Helicobacter pylori-induced focal adhesion kinase activation and cytoskeletal re-organizationFazal H Tabassam, David Y Graham, Yoshio Yamaoka
Cancer Science|August 22, 2009
Gastric mucosal interleukin-17 and -18 mRNA expression in Helicobacter pylori-induced Mongolian gerbilsMitsushige Sugimoto, Tomoyuki Ohno, David Y Graham, et al.
Inflammatory Bowel Diseases|January 17, 2017
Increasing Incidence of Crohn's Disease with Familial Clustering in the Kingdom of Bahrain: A 25-Year Population-based StudyNajah R Zayyani, Hoda M Malaty, David Y Graham
Helicobacter|April 7, 2005
Effect of the carbonic anhydrase inhibitor, acetazolamide, on Helicobacter pylori infection in vivo: a pilot studyRassa Shahidzadeh, Antone Opekun, Akiko Shiotani, et al.
The American Journal of Gastroenterology|September 19, 2024
Comparative Efficacy and Safety of Potassium-Competitive Acid Blocker-Based Dual, Triple, and Quadruple Regimens for First-Line Helicobacter pylori Infection Treatment: A Systematic Review and Network Meta-AnalysisTheodore Rokkas, Konstantinos Ekmektzoglou, Yaron Niv, et al.
Current Gastroenterology Reports|July 22, 2017
Changing Trends in Stomach Cancer Throughout the WorldMaya Balakrishnan, Rollin George, Ashish Sharma, et al.
Pageof 38

Showing results (91-100 of 373) with videos related to

Sort By:
Pageof 38
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 16, 2011
Paxillin is a novel cellular target for converging Helicobacter pylori-induced cellular signalingFazal H Tabassam, David Y Graham, Yoshio Yamaoka
Helicobacter|December 6, 2007
Contemplating the future without Helicobacter pylori and the dire consequences hypothesisDavid Y Graham, Yoshio Yamaoka, Hoda M Malaty
Clinical Medicine Insights. Case Reports|July 26, 2013
Toothpick perforation of the intestines presenting as recurrent abdominal pain: possible roles of abdominal ultrasound and MRIRobert J Sealock, Saman Sabounchi, David Y Graham
Nature Reviews. Gastroenterology & Hepatology|February 5, 2011
Optimal therapy for Helicobacter pylori infectionsEmiko Rimbara, Lori A Fischbach, David Y Graham
Cellular Microbiology|December 11, 2007
OipA plays a role in Helicobacter pylori-induced focal adhesion kinase activation and cytoskeletal re-organizationFazal H Tabassam, David Y Graham, Yoshio Yamaoka
Cancer Science|August 22, 2009
Gastric mucosal interleukin-17 and -18 mRNA expression in Helicobacter pylori-induced Mongolian gerbilsMitsushige Sugimoto, Tomoyuki Ohno, David Y Graham, et al.
Inflammatory Bowel Diseases|January 17, 2017
Increasing Incidence of Crohn's Disease with Familial Clustering in the Kingdom of Bahrain: A 25-Year Population-based StudyNajah R Zayyani, Hoda M Malaty, David Y Graham
Helicobacter|April 7, 2005
Effect of the carbonic anhydrase inhibitor, acetazolamide, on Helicobacter pylori infection in vivo: a pilot studyRassa Shahidzadeh, Antone Opekun, Akiko Shiotani, et al.
The American Journal of Gastroenterology|September 19, 2024
Comparative Efficacy and Safety of Potassium-Competitive Acid Blocker-Based Dual, Triple, and Quadruple Regimens for First-Line Helicobacter pylori Infection Treatment: A Systematic Review and Network Meta-AnalysisTheodore Rokkas, Konstantinos Ekmektzoglou, Yaron Niv, et al.
Current Gastroenterology Reports|July 22, 2017
Changing Trends in Stomach Cancer Throughout the WorldMaya Balakrishnan, Rollin George, Ashish Sharma, et al.
Pageof 38